Join
Live feed
·
INSIDERFilingvia Quantisnow
Immuneering Corporation logo

PRESIDENT AND CEO Zeskind Benjamin J. bought $10,948 worth of shares (2,400 units at $4.56), increasing direct ownership by 0.10% to 2,315,252 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IMRX· Immuneering Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMRX (Immuneering Corporation) and more on Quantisnow.

PRESIDENT AND CEO Zeskind Benjamin J. bought $10,948 worth of shares (2,400 units at $4.56), increasing direct ownership by 0.10% to 2,315,252 units (SEC Form 4) | Quantisnow